Sinopharm Medicine Holding To Set Up Southwest Pharmaceutical Distribution Center
This article was originally published in PharmAsia News
Sinopharm Medicine Holding, a subsidiary of Sinopharm, has signed an investment agreement with the Chengdu government to establish a RMB 100 million Sinopharm southwest pharmaceutical distribution center in Chengdu. Aiming to be the top distribution brand in the region, Sinopharm Medicine will first build a modernized pharmaceutical logistics center to transform from a traditional pharmaceutical wholesale enterprise to a progressive distributor. The facility will also provide more extended distribution channels for the southwest company's upstream clients as well as stronger logistics support for downstream customers. (Click here for more - Chinese Language)
You may also be interested in...
Lawyer asks US FDA to require another trial before licensing Mesoblast’s stem cell therapy for children with SR-aGVHD; Incyte’s Jakafi is only product approved for the indication.
Hanmi licenses out GLP-1/glucagon receptor dual agonist for NASH to Merck, in a deal worth up to $870m, marking a positive turn for the Korean firm's pipeline after Janssen returned rights last year.
Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading.